- Home
- Publications
- Publication Search
- Publication Details
Title
Aminopeptidase N (CD13) as a target for cancer chemotherapy
Authors
Keywords
-
Journal
CANCER SCIENCE
Volume 102, Issue 3, Pages 501-508
Publisher
Wiley
Online
2010-12-09
DOI
10.1111/j.1349-7006.2010.01826.x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The alkylating prodrug J1 can be activated by aminopeptidase N, leading to a possible target directed release of melphalan
- (2010) Malin Wickström et al. BIOCHEMICAL PHARMACOLOGY
- LYP, a novel bestatin derivative, inhibits cell growth and suppresses APN/CD13 activity in human ovarian carcinoma cells more potently than bestatin
- (2010) Jian-Jun Gao et al. INVESTIGATIONAL NEW DRUGS
- Phase II Study of Asparagine-Glycine-Arginine–Human Tumor Necrosis Factor α, a Selective Vascular Targeting Agent, in Previously Treated Patients With Malignant Pleural Mesothelioma
- (2010) Vanesa Gregorc et al. JOURNAL OF CLINICAL ONCOLOGY
- Nanoparticles Targeted With NGR Motif Deliver c-myc siRNA and Doxorubicin for Anticancer Therapy
- (2010) Yunching Chen et al. MOLECULAR THERAPY
- Infarction of tumor vessels by NGR-peptide-directed targeting of tissue factor: experimental results and first-in-man experience
- (2009) R. Bieker et al. BLOOD
- Phase Ib study of NGR–hTNF, a selective vascular targeting agent, administered at low doses in combination with doxorubicin to patients with advanced solid tumours
- (2009) V Gregorc et al. BRITISH JOURNAL OF CANCER
- A First-in-Man Phase I and Pharmacokinetic Study on CHR-2797 (Tosedostat), an Inhibitor of M1 Aminopeptidases, in Patients with Advanced Solid Tumors
- (2009) A. H.M. Reid et al. CLINICAL CANCER RESEARCH
- Defining the optimal biological dose of NGR-hTNF, a selective vascular targeting agent, in advanced solid tumours
- (2009) Vanesa Gregorc et al. EUROPEAN JOURNAL OF CANCER
- NGR-modified micelles enhance their interaction with CD13-overexpressing tumor and endothelial cells
- (2009) Xun Wang et al. JOURNAL OF CONTROLLED RELEASE
- Aminopeptidase N (APN)/CD13 inhibitor, Ubenimex, enhances radiation sensitivity in human cervical cancer
- (2008) Hirohisa Tsukamoto et al. BMC CANCER
- CHR-2797: An Antiproliferative Aminopeptidase Inhibitor that Leads to Amino Acid Deprivation in Human Leukemic Cells
- (2008) D. Krige et al. CANCER RESEARCH
- Enhanced Antitumor Efficacy of Clinical-Grade Vasculature-Targeted Liposomal Doxorubicin
- (2008) F. Pastorino et al. CLINICAL CANCER RESEARCH
- Aminopeptidase N (APN/CD13) as a Target for Anti-Cancer Agent Design
- (2008) Xiaopan Zhang et al. CURRENT MEDICINAL CHEMISTRY
- In vivo optical imaging of CD13/APN-expression in tumor xenografts
- (2008) Angelika von Wallbrunn et al. JOURNAL OF BIOMEDICAL OPTICS
- Vasculature-targeted tumor necrosis factor-alpha increases the therapeutic index of doxorubicin against prostate cancer
- (2008) Maria T.S. Bertilaccio et al. PROSTATE
- The moonlighting enzyme CD13: old and new functions to target
- (2008) Paola Mina-Osorio TRENDS IN MOLECULAR MEDICINE
- Conjugated Platinum(IV)−Peptide Complexes for Targeting Angiogenic Tumor Vasculature
- (2007) Sumitra Mukhopadhyay et al. BIOCONJUGATE CHEMISTRY
- Aminopeptidase N (APN)/CD13-dependent CXCR4 downregulation is associated with diminished cell migration, proliferation and invasion
- (2007) Jens Wulfaenger et al. MOLECULAR MEMBRANE BIOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now